Vetoquinol SA

Paris Stock Exchange VETO.PA

Vetoquinol SA Operating Cash Flow for the year ending December 31, 2023: USD 98.67 M

Vetoquinol SA Operating Cash Flow is USD 98.67 M for the year ending December 31, 2023, a 47.80% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Vetoquinol SA Operating Cash Flow for the year ending December 31, 2022 was USD 66.76 M, a -34.23% change year over year.
Vetoquinol SA Operating Cash Flow for the year ending December 31, 2021 was USD 101.50 M, a -9.69% change year over year.
Vetoquinol SA Operating Cash Flow for the year ending December 31, 2020 was USD 112.40 M, a 92.52% change year over year.
Vetoquinol SA Operating Cash Flow for the year ending December 31, 2019 was USD 58.38 M, a 34.65% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Paris Stock Exchange: VETO.PA

Vetoquinol SA

CEO	Mr. Alain Masson
IPO Date	Nov. 17, 2006
Location	France
Headquarters	Magny-Vernois
Employees	2,519
Sector	Consumers Staples
Industries Pet Food Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pharmaceuticals Vaccines

Description

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Key trends

Past 5 years